- Home
- ONMD vs IPSC Comparison
ONMD vs IPSC Comparison
Compare ONMD & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- IPSC
- Stock Information
- Founded
- ONMD 2006
- IPSC 2019
- Country
- ONMD United States
- IPSC United States
- Employees
- ONMD N/A
- IPSC N/A
- Industry
- ONMD
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ONMD
- IPSC Health Care
- Exchange
- ONMD Nasdaq
- IPSC Nasdaq
- Market Cap
- ONMD 38.9M
- IPSC 43.6M
- IPO Year
- ONMD N/A
- IPSC 2021
- Fundamental
- Price
- ONMD $0.89
- IPSC $0.49
- Analyst Decision
- ONMD
- IPSC Strong Buy
- Analyst Count
- ONMD 0
- IPSC 5
- Target Price
- ONMD N/A
- IPSC $3.33
- AVG Volume (30 Days)
- ONMD 1.6M
- IPSC 539.5K
- Earning Date
- ONMD 08-13-2025
- IPSC 11-04-2025
- Dividend Yield
- ONMD N/A
- IPSC N/A
- EPS Growth
- ONMD N/A
- IPSC N/A
- EPS
- ONMD N/A
- IPSC N/A
- Revenue
- ONMD $459,000.00
- IPSC $114,128,000.00
- Revenue This Year
- ONMD N/A
- IPSC $1,589.94
- Revenue Next Year
- ONMD N/A
- IPSC N/A
- P/E Ratio
- ONMD N/A
- IPSC N/A
- Revenue Growth
- ONMD N/A
- IPSC 5491.77
- 52 Week Low
- ONMD $0.30
- IPSC $0.34
- 52 Week High
- ONMD $1.56
- IPSC $1.86
- Technical
- Relative Strength Index (RSI)
- ONMD 59.80
- IPSC 43.80
- Support Level
- ONMD $0.82
- IPSC $0.48
- Resistance Level
- ONMD $0.92
- IPSC $0.52
- Average True Range (ATR)
- ONMD 0.07
- IPSC 0.02
- MACD
- ONMD -0.01
- IPSC 0.00
- Stochastic Oscillator
- ONMD 74.43
- IPSC 60.00
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.